Asthma Therapeutics Market Report

Asthma Therapeutics Market Analysis By Drug Class (Anti-inflammatory, Bronchodilators, Combination Therapy), By Device Type (Inhalers, Dry Powder, Metered Dose, Soft Mist, Nebulizers), By Route Of Administration (Oral, Inhaled, Intravenous, Subcutaneous) And Segment Forecasts To 2024

  • Published Date: Jul 2016
  • Report ID: 978-1-68038-936-4
  • Number of Pages: 126
  • Format: Electronic (PDF)
  • Historical Data: 2013-2015

Table of Content

Chapter 1 Research Methodology & Scope
                         1.1 Region Wise Market Calculation
                             1.1.1 Region Wise Market: Base Estimates
                             1.1.2 Global Market: CAGR Calculation
                         1.2 Region based segment share calculation
                         1.3 List of Secondary Sources
Chapter 2 Executive Summary
Chapter 3 Market Snapshot
Chapter 4 Market Variables, Trends & Scope
                         4.1 Market segmentation & scope
                             4.1.1 Market Driver Analysis
                                   4.1.1.2 Increasing incidences
                                   4.1.1.3 Introduction of novel biologics
                                   4.1.1.4 Rising government initiatives
                             4.1.2 Market Restraint Analysis
                         4.2 Penetration & growth prospect mapping
                         4.3 Asthma Therapeutics - SWOT Analysis, By Factor (political & legal, economic and technological)
                         4.4 Industry Analysis - Porter’s
Chapter 5 Market Categorization 1: Drug Class Estimates & Trend Analysis
                         5.1 Asthma therapeutics market: drug class movement analysis
                         5.2 Anti-inflammatory
                             5.2.1 Anti-inflammatory market, 2013 - 2024 (USD Million)
                         5.3 Bronchodilators
                             5.3.1 Bronchodilators market, 2013 - 2024 (USD Million)
                         5.4 Combination therapy
                             5.4.1 Combination therapy market, 2013 - 2024 (USD Million)
Chapter 6 Market Categorization 2: Product Estimates & Trend Analysis
                         6.1 Asthma therapeutics market: product movement analysis
                         6.2 Inhalers
                             6.2.1 Inhalers market, 2013 - 2024 (USD Million)
                             6.2.2 Dry powder inhalers market, 2013 - 2024 (USD Million)
                             6.2.3 Metered-dose inhalers market, 2013 - 2024 (USD Million)
                             6.2.4 Soft mist inhalers market, 2013 - 2024 (USD Million)
                         6.3 Nebulizers
                             6.3.1 Nebulizers market, 2013 - 2024 (USD Million)
Chapter 7 Market Categorization 3: Route of Administration Estimates & Trend Analysis
                         7.1 Asthma therapeutics market: route of administration movement analysis
                         7.2 Oral
                             7.2.1 Oral market, 2013 - 2024 (USD Million)
                         7.3 Inhaled
                             7.3.1 Inhaled market, 2013 - 2024 (USD Million)
                         7.4 Others
                             7.4.1 Others market, 2013 - 2024 (USD Million)
Chapter 8 Market Categorization 4: Regional Estimates & Trend Analysis, by Drug class, Product & Route of Administration
                         8.1 Asthma therapeutics market share by region, 2015 & 2024
                         8.2 North America
                             8.2.1 U.S.
                             8.2.2 Canada
                         8.3 Europe
                             8.3.1 UK
                             8.3.2 Germany
                         8.4 Asia Pacific
                             8.4.1 Japan
                             8.4.2 China
                             8.4.3 India
                         8.5 Latin America
                             8.5.1 Mexico
                             8.5.2 Brazil
                         8.6 MEA
                             8.6.1 South Africa
Chapter 9 Competitive Landscape
                         9.1 Strategy framework
                         9.2 Market participation categorization
                         9.3 Company Profiles
                             9.3.1 Teva Pharmaceutical Industries Ltd.
                                   9.3.1.1 Company Overview
                                   9.3.1.2 Financial Performance
                                   9.3.1.3 Product Benchmarking
                                   9.3.1.4 Strategic Initiatives
                             9.3.2 GlaxoSmithKline Plc
                                   9.3.2.1 Company Overview
                                   9.3.2.2 Financial Performance
                                   9.3.2.3 Product Benchmarking
                                   9.3.2.4 Strategic Initiatives
                             9.3.3 Merck& Co., Inc.
                                   9.3.3.1 Company Overview
                                   9.3.3.2 Financial Performance
                                   9.3.3.3 Product Benchmarking
                                   9.3.3.4 Strategic Initiatives
                             9.3.4 Roche Diagnostics
                                   9.3.4.1 Company Overview
                                   9.3.4.2 Financial Performance
                                   9.3.4.3 Product Benchmarking
                                   9.3.4.4 Strategic Initiatives
                             9.3.5 AstraZeneca Plc
                                   9.3.5.1 Company Overview
                                   9.3.5.2 Financial Performance
                                   9.3.5.3 Product Benchmarking
                                   9.3.5.4 Strategic Initiatives
                             9.3.6 Boehringer Ingelheim GmbH
                                   9.3.6.1 Company Overview
                                   9.3.6.2 Financial Performance
                                   9.3.6.3 Product Benchmarking
                                   9.3.6.4 Strategic Initiatives
                             9.3.7 Sanofi-Aventis SA
                                   9.3.7.1 Company Overview
                                   9.3.7.2 Financial Performance
                                   9.3.7.3 Product Benchmarking
                                   9.3.7.4 Strategic Initiatives
                             9.3.8 Philips Healthcare
                                   9.3.8.1 Company Overview
                                   9.3.8.2 Financial Performance
                                   9.3.8.3 Product Benchmarking
                                   9.3.8.4 Strategic Initiatives
                             9.3.9 CareFusion Corporation
                                   9.3.9.1 Company Overview
                                   9.3.9.2 Financial Performance
                                   9.3.9.3 Product Benchmarking
                                   9.3.9.4 Strategic Initiatives
                             9.3.10 Sunovion Pharmaceuticals, Inc.
                                   9.3.10.1 Company Overview
                                   9.3.10.2 Financial Performance
                                   9.3.10.3 Product Benchmarking
                                   9.3.10.4 Strategic Initiatives


List of Tables

TABLE 1 Country share estimation
TABLE 2 North America asthma therapeutics market, by drug class, 2013 - 2024 (USD Million)
TABLE 3 North America asthma therapeutics market, by product, 2013 - 2024 (USD Million)
TABLE 4 North America inhalers market, by type, 2013 - 2024 (USD Million)
TABLE 5 North America asthma therapeutics market, by route of administration, 2013 - 2024 (USD Million)
TABLE 6 U.S. asthma therapeutics market, by drug class, 2013 - 2024 (USD Million)
TABLE 7 U.S. asthma therapeutics market, by product, 2013 - 2024 (USD Million)
TABLE 8 U.S. inhalers market, by type, 2013 - 2024 (USD Million)
TABLE 9 U.S. asthma therapeutics market, by route of administration, 2013 - 2024 (USD Million)
TABLE 10 Canada asthma therapeutics market, by drug class, 2013 - 2024 (USD Million)
TABLE 11 Canada asthma therapeutics market, by product, 2013 - 2024 (USD Million)
TABLE 12 Canada inhalers market, by type, 2013 - 2024 (USD Million)
TABLE 13 Canada asthma therapeutics market, by route of administration, 2013 - 2024 (USD Million)
TABLE 14 Europe asthma therapeutics market, by drug class, 2013 - 2024 (USD Million)
TABLE 15 Europe asthma therapeutics market, by product, 2013 - 2024 (USD Million)
TABLE 16 Europe inhalers market, by type, 2013 - 2024 (USD Million)
TABLE 17 Europe asthma therapeutics market, by route of administration, 2013 - 2024 (USD Million)
TABLE 18 UK asthma therapeutics market, by drug class, 2013 - 2024 (USD million)
TABLE 19 UK asthma therapeutics market, by product, 2013 - 2024 (USD Million)
TABLE 20 UK inhalers market, by type, 2013 - 2024 (USD Million)
TABLE 21 UK asthma therapeutics market, by route of administration, 2013 - 2024 (USD Million)
TABLE 22 Germany asthma therapeutics market, by drug class, 2013 - 2024 (USD Million)
TABLE 23 Germany asthma therapeutics market, by product, 2013 - 2024 (USD Million)
TABLE 24 Germany inhalers market, by type, 2013 - 2024 (USD Million)
TABLE 25 Germany asthma therapeutics market, by route of administration, 2013 - 2024 (USD Million)
TABLE 26 Asia Pacific asthma therapeutics market, by drug class, 2013 - 2024 (USD Million)
TABLE 27 Asia Pacific asthma therapeutics market, by product, 2013 - 2024 (USD Million)
TABLE 28 Asia Pacific inhalers market, by type, 2013 - 2024 (USD Million)
TABLE 29 Asia Pacific asthma therapeutics market, by route of administration, 2013 - 2024 (USD Million)
TABLE 30 Japan asthma therapeutics market, by drug class, 2013 - 2024 (USD Million)
TABLE 31 Japan asthma therapeutics market, by product, 2013 - 2024 (USD Million)
TABLE 32 Japan inhalers market, by type, 2013 - 2024 (USD Million)
TABLE 33 Japan asthma therapeutics market, by route of administration, 2013 - 2024 (USD Million)
TABLE 34 China asthma therapeutics market, by drug class, 2013 - 2024 (USD Million)
TABLE 35 China asthma therapeutics market, by product, 2013 - 2024 (USD Million)
TABLE 36 China inhalers market, by type, 2013 - 2024 (USD Million)
TABLE 37 China asthma therapeutics market, by route of administration, 2013 - 2024 (USD Million)
TABLE 38 India asthma therapeutics market, by drug class, 2013 - 2024 (USD Million)
TABLE 39 India asthma therapeutics market, by product, 2013 - 2024 (USD Million)
TABLE 40 India inhalers market, by type, 2013 - 2024 (USD Million)
TABLE 41 India asthma therapeutics market, by route of administration, 2013 - 2024 (USD Million)
TABLE 42 Latin America asthma therapeutics market, by drug class, 2013 - 2024 (USD Million)
TABLE 43 Latin America asthma therapeutics market, by product, 2013 - 2024 (USD Million)
TABLE 44 Latin America inhalers market, by type, 2013 - 2024 (USD Million)
TABLE 45 Latin America asthma therapeutics market, by route of administration, 2013 - 2024 (USD Million)
TABLE 46 Mexico asthma therapeutics market, by drug class, 2013 - 2024 (USD Million)
TABLE 47 Mexico asthma therapeutics market, by product, 2013 - 2024 (USD Million)
TABLE 48 Mexico inhalers market, by type, 2013 - 2024 (USD Million)
TABLE 49 Mexico asthma therapeutics market, by route of administration, 2013 - 2024 (USD Million)
TABLE 50 Brazil asthma therapeutics market, by drug class, 2013 - 2024 (USD Million)
TABLE 51 Brazil asthma therapeutics market, by product, 2013 - 2024 (USD Million)
TABLE 52 Brazil inhalers market, by type, 2013 - 2024 (USD Million)
TABLE 53 Brazil asthma therapeutics market, by route of administration, 2013 - 2024 (USD Million)
TABLE 54 MEA asthma therapeutics market, by drug class, 2013 - 2024 (USD Million)
TABLE 55 MEA asthma therapeutics market, by product, 2013 - 2024 (USD Million)
TABLE 56 MEA inhalers market, by type, 2013 - 2024 (USD Million)
TABLE 57 MEA asthma therapeutics market, by route of administration, 2013 - 2024 (USD Million)
TABLE 58 South Africa asthma therapeutics market, by drug class, 2013 - 2024 (USD Million)
TABLE 59 South Africa asthma therapeutics market, by product, 2013 - 2024 (USD Million)
TABLE 60 South Africa inhalers market, by type, 2013 - 2024 (USD Million)
TABLE 61 South Africa asthma therapeutics market, by route of administration, 2013 - 2024 (USD Million)


List of Figures

FIG. 1 Market summary
FIG. 2 Market trends & outlook
FIG. 3 Asthma Therapeutics: Market Segmentation
FIG. 4 Market driver relevance analysis (Current & future impact)
FIG. 5 Disease incidence rates per 100,000, by type, 2013
FIG. 6 Market restraint analysis (Current & future impact)
FIG. 7 Penetration & growth prospect mapping
FIG. 8 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 9 Asthma Therapeutics: Porter’s analysis
FIG. 10 Asthma therapeutics market drug class outlook key takeaways
FIG. 11 Asthma therapeutics market: drug class movement analysis
FIG. 12 Global anti-inflammatory market, 2013 - 2024 (USD Million)
FIG. 13 Global bronchodilators market, 2013 - 2024 (USD Million)
FIG. 14 Global combination therapy market, 2013 - 2024 (USD Million)
FIG. 15 Asthma therapeutics market product outlook key takeaways
FIG. 16 Asthma therapeutics market: product movement analysis
FIG. 17 Global inhalers market, 2013 - 2024 (USD Million)
FIG. 18 Global dry powder inhalers market, 2013 - 2024 (USD Million)
FIG. 19 Global metered dose inhalers market, 2013 - 2024 (USD Million)
FIG. 20 Global soft mist inhalers market, 2013 - 2024 (USD Million)
FIG. 21 Global nebulizers market, 2013 - 2024 (USD Million)
FIG. 22 Asthma therapeutics market route of administration outlook: Key takeaways
FIG. 23 Asthma therapeutics market: route of administration movement analysis
FIG. 24 Global oral drugs market, 2013 - 2024 (USD Million)
FIG. 25 Global inhaled drugs market, 2013 - 2024 (USD Million)
FIG. 26 Global other drugs market, 2013 - 2024 (USD Million)
FIG. 27 Regional marketplace: Key takeaways
FIG. 28 Regional outlook, 2015 & 2024
FIG. 29 Strategy framework
FIG. 30 Participant categorization

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.